57,852 results on '"Influenza, Human"'
Search Results
202. Influenza Immunization in Adults Over Age 75
203. Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients
204. A Study of the GRIP Influenza and SARS-CoV-2 POC Assays
205. Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine (CoVFlu)
206. Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1
207. A Study of Modified mRNA Vaccines in Healthy Adults
208. Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A
209. Performance Evaluation of the Lucira COVID-19 & Flu Test
210. Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23
211. A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza
212. Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older
213. A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old
214. Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome
215. A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.
216. A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults
217. Efficacy Study With QIVc in Pediatric Subjects
218. Agaricus Bisporus and Influenza Vaccination Response
219. Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
220. Equity Evaluation of Fact Boxes on Informed COVID-19 and Influenza Vaccination Decisions - Study Protocol
221. A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19
222. Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients (FLUO)
223. Evaluation of Humoral Immunity Following COVID-19 in Pregnancy (ImmunoCOVID)
224. A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine
225. Vaccine Pandemic Preparedness Through Airway Immunology Characterization (VAXXAIR)
226. Effect of Health Education on Promoting Influenza Vaccination Health Literacy
227. Effectiveness of a Nasal Spray on Viral Respiratory Infections
228. Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine
229. Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine
230. InfluenCEF Study: Study on the Headache Associated With Influenza Infection (INFLUENCEF)
231. Dose, Safety, and Pathogenicity of a New Influenza B Strain
232. The Role of Cxcr4Hi neutrOPhils in InflueNza (CHOPIN)
233. Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers (COVAGRIP)
234. Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis. (VACCINE-CHF)
235. Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)
236. Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza
237. A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
238. Response to Influenza Vaccine During Pregnancy (FLU-PG)
239. Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort (SLVP033)
240. A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old
241. Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Kidney Transplant Recipients -ChronoVAX (CHRONOVAX)
242. Bone Marrow and Peripheral Blood Immune Responses Study
243. Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test (INFORM)
244. Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.
245. Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin (TETRALITE-I)
246. A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age (ICICLE)
247. Evaluation of a Screen and Treat Protocol for Influenza
248. Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children
249. Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection
250. Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.